Presentation is loading. Please wait.

Presentation is loading. Please wait.

Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION.

Similar presentations


Presentation on theme: "Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION."— Presentation transcript:

1 TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION

2 Introduction

3 Pathological Distinctions Between CRC Tumors

4 mCRC: Sidedness and Outcomes

5 Relevance of PTL in mCRC: What Is the Impact on Clinical Decisions?

6 Case 1: Left-Sided mCRC

7 Treatment Options for Left-Sided mCRC

8 Treatment-Related AEs Associated With EGFR Inhibitors

9 CT ± Cetuximab in Patients With Resectable Colorectal Liver Metastasis: New EPOC Study

10 ESMO Consensus Guidelines for the Management of Patients With mCRC

11 NCCN Guidelines for the Treatment of Colon Cancer

12 Case 2: Right-Sided CRC

13 PTL in mCRC: Meta-Analysis Findings

14 EGFR Inhibitor-Associated Dermatologic Toxicities

15 Molecular Biomarker Testing for the Evaluation of CRC

16 Transverse CRC: Shared Embryology, Pathology, and Genetics

17 The Use of Tumor Sidedness as a Potential Surrogate Marker

18 Concluding Remarks


Download ppt "Introduction. TREATMENT BASED ON TUMOR SIDEDNESS IN mCRC: THE EVIDENCE AND PRACTICAL APPLICATION."

Similar presentations


Ads by Google